[Cis-diamminedichloroplatinum (CDDP)-radiation therapy of an advanced nasopharyngeal carcinoma]. 1989

M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
Dept. Otolaryngology-Head and Neck Surgery, Center for Adult Diseases, Osaka.

Between November 1983 and May 1985, 11 patients with locally advanced (stage IV) nasopharyngeal carcinoma were treated using a combination of Cis-diamminedichloroplatinum and radiation therapy (CDDP-RT group). In this group, 7 patients were given radical RT, sandwiched between 1 course of CDDP (70 mg/m2) before and 1 after. Four patients were given 1 course of CDDP prior to RT. Treatment results were compared with 32 patients (stage IV) who were treated with radiation therapy alone (RT group). These groups showed almost the same local control rate and distant relapses. There was no significant difference in the actuarial and relapse-free survival between the CDDP-RT group and the RT group. As a side effect, severe mucositis of the oral cavity was observed in 4 patients (36%) of the CDDP-RT group in contrast with 3 patients (9%) of the RT group (p less than 0.05).

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal

Related Publications

M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
March 1988, International journal of radiation oncology, biology, physics,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
June 1984, Tumori,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
December 1984, Hinyokika kiyo. Acta urologica Japonica,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
September 1984, Hinyokika kiyo. Acta urologica Japonica,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
October 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
November 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
January 1984, Cancer chemotherapy and pharmacology,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
April 1993, Journal of neuro-oncology,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
January 1980, Cancer treatment reports,
M Chatani, and T Teshima, and T Inoue, and K Umatani, and K Yoshino, and T Sato
January 1981, Medical and pediatric oncology,
Copied contents to your clipboard!